Welcome to Shanghai KASONS Technology Co., Ltd.
Back to resources
Product Updates

Glycosyloxazolines: precision tool molecules for glycobiology research and therapy 1065008-93-6

Today, with the rapid development of glycoscience, glycosylation modification, as one of the most extensive and complex post-translational modifications in life processes, is increasingly becoming the forefront focus of disease treatment and biopharmaceuticals. Glycan Oxazoline, especially mannosylated oxazoline derivatives with precisely defined structures, is gradually becoming an indispensable high-value molecular tool in glycoengineering, glycoprotein synthesis and sugar-related drug development due to its unique chemical properties and biological functions. Such compounds not only represent an advanced achievement in glycochemical synthesis, but also provide a key entry point to peer into sugar-biological macromolecule interactions and develop the next generation of glycosylation therapies.

Today, with the rapid development of glycoscience, glycosylation modification, as one of the most extensive and complex post-translational modifications in life processes, is increasingly becoming the forefront focus of disease treatment and biopharmaceuticals. Glycan Oxazoline, especially mannosylated oxazoline derivatives with precisely defined structures, is gradually becoming an indispensable high-value molecular tool in glycoengineering, glycoprotein synthesis and sugar-related drug development due to its unique chemical properties and biological functions. Such compounds not only represent an advanced achievement in glycochemical synthesis, but also provide a key entry point to peer into sugar-biological macromolecule interactions and develop the next generation of glycosylation therapies.

Chemical Information

Chemical name: β-D-Glucopyranoside,(3aR,5R,6S,7R,7aR)-3a,6,7,7a-tetrahydro-7-hydroxy-5-(hydroxymethyl) -2-methyl-5H-pyrano[3,2-d]oxazol-6-ylO-α-D-mannopyranosyl-(1→3)-O-[α-D-mannopyranosyl-(1→6)]-

Common name: Mannosylated oxazoline derivatives

Chemical formula: C26H43NO20

Molecular weight: 689.62 g/mol

CAS number: 1065008-93-6

Category: Glycan Oxazoline

Structural features

This compound is an exquisitely structured Glycan Oxazoline. Its core features combine oxazoline heterocycles with precisely orchestrated oligosaccharide chains, reflecting multi-layered chemical uniqueness:

Stable oxazoline core: The molecular center contains a 2-methyl-5H-pyrano[3,2-d]oxazoline ring system. This oxazoline structure is known for its ring tension and reactivity, and is often used as an efficient glycosylation donor intermediate in glycochemistry. Its stereochemical configuration (3aR, 5R, 6S, 7R, 7aR) ensures the rigidity of the structure and the specificity of interaction with biological enzymes.

Precise oligosaccharide structure: Position 6 of the oxazoline ring is connected to a β-D-glucopyranoside through a glycosidic bond, and the glucose base is further modified by a highly branched mannobiose chain. Specifically, there are double connections of O-α-D-mannopyranosyl-(1→3) and O-[α-D-mannopyranosyl-(1→6)], forming a characteristic mannose (α1-3, α1-6) branched structure. This pattern mimics the high-mannose or hybrid branching of N-linked sugar chains commonly found in natural glycoproteins, providing the molecule with specific sugar recognition potential.

Multifunctional functional groups: The molecule also contains polar groups such as hydroxyl and hydroxymethyl groups, ensuring good water solubility and compatibility with biological environments, while providing convenient sites for further chemical derivatization. The overall structure combines stability and reactivity, making it an ideal structural module.

Main applications and advantages

Key intermediates in glycoprotein synthesis and glycoengineering

Glycan Oxazoline is a favored donor substrate in enzymatic glycosylation reactions. In particular, endoglycosidases (Endoglycosidases) and their engineered variants (such as Endo-A, Endo-M, Endo-S, etc.) can efficiently catalyze the transglycosylation reaction between such oxazoline derivatives and glycoprotein receptors (such as antibody Fc segments, specific asparagine sites), achieving uniform, site-specific sugar chain remodeling or glycoprotein synthesis. The branched structure of mannosylation is directly applicable to the preparation of high-mannose or complex N-glycan modified glycoproteins, which is crucial for studying how glycosylation affects protein folding, stability, immunogenicity and biological activity, and can be used to develop and optimize therapeutic antibodies, enzyme replacement therapies and vaccine antigens.

Probes for studying glycobiological mechanisms

Mannose-specific lectins (such as DC-SIGN, MBL, etc.) and intracellular mannose receptors play central roles in immune recognition, pathogen infection, and cell signal transduction. Mannosylated oxazolines with well-defined structures can be used as molecular probes to study the binding specificity, affinity and structure-activity relationship of these receptors. Surface plasmon resonance (SPR), isothermal titration calorimetry (ITC) or cell binding experiments can help elucidate the molecular basis of sugar-protein interactions and provide lead structures for drug design based on sugar recognition (such as antiviral inhibitors, immunomodulators).

Cornerstone for the development of sugar-related drugs and diagnostic tools

Abnormal glycosylation is an important hallmark of cancer, autoimmune diseases, congenital disorders of glycosylation (CDG), and infectious diseases. This compound can be used as a standard or reference molecule for mass spectrometry or chromatography analysis of disease-related sugar profile changes to facilitate biomarker discovery. In addition, its high efficiency in enzymatic synthesis supports the rapid construction of structurally uniform sugar clusters, sugar arrays or sugar nanoparticles. These materials have broad application prospects in targeted delivery, molecular imaging and in vitro diagnostic reagent development. Compared with traditional chemical glycosylation methods, the use of well-designed oxazoline donors usually has the advantages of mild conditions, high yields, and good stereoselectivity.

Conclusion

From the basic scientific exploration of decoding the sugar code to the translational medicine practice of creating a new generation of glycosylated biologics, the structurally precise mannosylated GlycanOxazoline represents a powerful tool that blends the intelligence of chemical synthesis with biological function. Its value in customized synthesis of glycoproteins, analysis of host-pathogen interactions, and development of sugar-targeted therapies is constantly being explored. As glycoscience plays an increasingly important role in precision medicine, this type of molecules will surely contribute more key solutions to human health.

The above information is provided by the editor of KASONS and is for scientific research only.